| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.81▼ | 6.81▼ | 6.82▼ | 6.93▼ | 7.11▼ |
| MA10 | 6.91▼ | 6.89▼ | 7.00▼ | 7.21▼ | 7.09▼ |
| MA20 | 7.12▼ | 7.15▼ | 7.25▼ | 7.33▼ | 8.67▼ |
| MA50 | 7.34▼ | 7.29▼ | 7.53▼ | 7.43▼ | 9.77▼ |
| MA100 | 7.34▼ | 7.31▼ | 7.12▼ | 9.34▼ | 11.47▼ |
| MA200 | 7.00▼ | 7.75▼ | 8.47▼ | 10.58▼ | 17.35▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.042▼ | -0.049▼ | -0.069▼ | -0.055▼ | -0.161▼ |
| RSI | 38.388▼ | 38.330▼ | 36.735▼ | 42.660▼ | 42.171▼ |
| STOCH | 5.878▼ | 5.037▼ | 3.033▼ | 34.780 | 41.246 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -74.627 | -72.209 |
| CCI | -103.295▼ | -90.101 | -99.025 | -98.147 | -70.152 |
|
Monday, August 04, 2025 02:01 PM
Exicure, Inc. ("Exicure" or the "Company") (Nasdaq: XCUR) a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that, as of July 1, 2025, the Company ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/08/25 | 6.90 | 6.90 | 6.70 | 6.70 | 8,029 |
| 15/08/25 | 6.85 | 6.9999 | 6.65 | 6.65 | 19,204 |
| 14/08/25 | 7.025 | 7.025 | 6.85 | 6.85 | 4,243 |
| 13/08/25 | 7.35 | 7.80 | 6.75 | 7.15 | 40,922 |
| 12/08/25 | 7.56 | 7.92 | 7.232 | 7.30 | 32,548 |
| 11/08/25 | 7.15 | 7.76 | 7.00 | 7.58 | 41,336 |
| 08/08/25 | 7.67 | 7.675 | 7.294 | 7.45 | 154,200 |
| 07/08/25 | 7.475 | 7.87 | 7.1306 | 7.36 | 41,911 |
| 06/08/25 | 7.41 | 8.00 | 7.41 | 7.69 | 34,300 |
| 05/08/25 | 7.17 | 8.01 | 7.17 | 7.40 | 40,500 |
|
|
||||
|
|
||||
|
|